• According to a recent note by analyst James Reddoch of Friedman, Billings, Ramsey, an injunction hearing related to the molecule is scheduled for Jan. 30.

    FORBES: Magazine Article

  • But James Reddoch at Friedman, Billings, Ramsey has written notes to investors saying that Reclast is, in fact pretty good--and that its efficacy will be hard to beat.

    FORBES: Amgen's Next Opponents

  • Fifth Third Bancorp gets the thumbs-down from Bradley Vander Ploeg at Raymond James and Gary Townsend at Friedman Billings Ramsey.

    FORBES: When Picky Analysts Pick

  • James Reddoch, an analyst Friedman, Billings, Ramsey, used prescription data from NDC Health to forecast the performance of biotech companies that he covers.

    FORBES: Two Picks In Biotech Ahead Of Earnings

  • But the number of patients getting the medicine could double, according to a research note from James Reddoch, biotech analyst at Friedman, Billings, Ramsey.

    FORBES

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定